Alnylam Pharmaceuticals is responsible for the funding and content of this website. The site is intended for the general public in Europe, Middle East and Africa for disease awareness purposes only. Nothing on the site constitutes individual medical advice. Individuals are advised to consult their physician or other appropriate HCP. PH1-CEMEA-00034 April 2021
PH1-DEU-00052 | Juni 2022
section reference container mb-35
You are now leaving LivingWithPH1.eu
Links to all outside sites are provided as a reference for our visitors. Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.